Skelsey M - Search Results

1

Induction of early growth response protein-1 gene expression in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.

Espey LL, Ujioka T, Russell DL, Skelsey M, Vladu B, Robker RL, Okamura H, Richards JS. Espey LL, et al. Among authors: skelsey m. Endocrinology. 2000 Jul;141(7):2385-91. doi: 10.1210/endo.141.7.7582. Endocrinology. 2000. PMID: 10875238

2

Characterization of ovarian carbonyl reductase gene expression during ovulation in the gonadotropin-primed immature Rat.

Espey LL, Yoshioka S, Russell D, Ujioka T, Vladu B, Skelsey M, Fujii S, Okamura H, Richards JS. Espey LL, et al. Among authors: skelsey m. Biol Reprod. 2000 Feb;62(2):390-7. doi: 10.1095/biolreprod62.2.390. Biol Reprod. 2000. PMID: 10642578

3

Gamma delta T cells are needed for ocular immune privilege and corneal graft survival.

Skelsey ME, Mellon J, Niederkorn JY. Skelsey ME, et al. J Immunol. 2001 Apr 1;166(7):4327-33. doi: 10.4049/jimmunol.166.7.4327. J Immunol. 2001. PMID: 11254685

4

CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye.

Skelsey ME, Mayhew E, Niederkorn JY. Skelsey ME, et al. Immunology. 2003 Sep;110(1):18-29. doi: 10.1046/j.1365-2567.2003.01676.x. Immunology. 2003. PMID: 12941137 Free PMC article.

5

Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation.

Skelsey ME, Mayhew E, Niederkorn JY. Skelsey ME, et al. Invest Ophthalmol Vis Sci. 2003 Dec;44(12):5242-51. doi: 10.1167/iovs.03-0768. Invest Ophthalmol Vis Sci. 2003. PMID: 14638723

6

Skin Cancer Risk Is Increased by Somatic Mutations Detected Noninvasively in Healthy-Appearing Sun-Exposed Skin.

Kaur K, Ai R, Perry AG, Riley B, Roberts EL, Montano EN, Han J, Roacho J, Lopez BG, Skelsey MK, Childs MV, Childs JN, Dobak J, Ibarra C, Jansen B, Clarke LE, Stone S, Whitaker JW. Kaur K, et al. Among authors: skelsey mk. J Invest Dermatol. 2024 Mar 19:S0022-202X(24)00176-3. doi: 10.1016/j.jid.2024.02.017. Online ahead of print. J Invest Dermatol. 2024. PMID: 38513819 Free article.

7

Patients' willingness to accept adverse event and cost tradeoffs from oral nicotinamide for reduced risk of non-melanoma skin cancer.

Boeri M, Skelsey MK, Schiro JA, Dozier SE, Glinert R, Okun MM. Boeri M, et al. Among authors: skelsey mk. J Dermatolog Treat. 2023 Dec;34(1):2247105. doi: 10.1080/09546634.2023.2247105. J Dermatolog Treat. 2023. PMID: 37587862 Free article. Clinical Trial.

8

Response to Marchetti et al.

Rigel DS, Whitaker JW, Skelsey MK, Peck G, Howell MD, Jansen B. Rigel DS, et al. Among authors: skelsey mk. J Invest Dermatol. 2022 Jan;142(1):232-234. doi: 10.1016/j.jid.2021.06.024. Epub 2021 Jul 15. J Invest Dermatol. 2022. PMID: 34273350 Free article. No abstract available.

9

Real-World Utility of a Non-Invasive Gene Expression Test to Rule Out Primary Cutaneous Melanoma: A Large US Registry Study.

Brouha B, Ferris LK, Skelsey MK, Peck G, Moy R, Yao Z, Jansen B. Brouha B, et al. Among authors: skelsey mk. J Drugs Dermatol. 2020 Mar 1;19(3):257-262. J Drugs Dermatol. 2020. PMID: 32550693 No abstract available.

10

Corrigendum: Impact on clinical practice of a non-invasive gene expression melanoma rule-out test: 12-month followup of negative test results and utility data from a large US registry study.

Ferris LK, Rigel DS, Siegel DM, Skelsey MK, Peck GL, Hren C, Gorman C, Frumento T, Jansen B, Yao Z, Rock J, Knezevich SR, Cockerell CJ. Ferris LK, et al. Among authors: skelsey mk. Dermatol Online J. 2019 Jun 6;25(6):13030/qt452297hk. Dermatol Online J. 2019. PMID: 31329399 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page